Biocause Pharma(000627)
Search documents
*ST天茂(000627)被证监会立案调查,受损股民可索赔
Xin Lang Cai Jing· 2025-12-12 01:25
受损股民可至新浪股民维权平台登记该公司维权:http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们! 2025年5月7日,天茂实业集团股份有限公司(证券代码:000627)发布《关于收到中国证券监督管理委 员会立案告知书的公告》。 公告显示,公司于2025年5月6日收到中国证券监督管理委员会下发的《立案告知书》(证监立案字 00502025004号)。根据《立案告知书》,因公司涉嫌未按期披露定期报告,根据《中华人民共和国证 券法》《中华人民共和国行政处罚法》等法律法规,中国证监会决定对公司立案。 登录新浪财经APP 搜索【信披】查看更多考评等级 此次立案直接源于公司此前公告。2025年4月28日晚间,公司宣布无法按原计划在4月29日披露2024年年 度报告和2025年第一季度报告,并提示可能无法在法定期限(4月30日)前完成披露,此举引发了市场 对其信息披露合规性的重大担忧。该事件导致公司股票于2025年7月8日起被实施退市风险警示,简称 由"天茂集团"变更为"*ST天茂"。此后,公司于2025年 ...
2025年1-10月北京市原保险保费收入共计3424.51亿元,同比增长9.78%
Chan Ye Xin Xi Wang· 2025-12-05 03:07
2020年-2025年1-10月北京市累计原保险保费收入统计图 上市企业:天茂集团(000627),中国平安(601318),中国人保(601319),新华保险(601336), 中国太保(601601),中国人寿(601628) 相关报告:智研咨询发布的《2026-2032年中国保险行业发展分析及投资前景预测报告》 2025年1-10月北京市原保险保费收入共计3424.51亿元,同比增长9.78%,北京市累计原保险保费收入不 同险种类别中寿险占比最高,为2357.55亿元,占比68.84%。 数据来源:国家金融监督管理总局,智研咨询整理 知前沿,问智研。智研咨询是中国一流产业咨询机构,十数年持续深耕产业研究领域,提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力,专注于提供完善的产业解决方案,为您的投资决策赋能。 ...
2025年1-10月全国原保险保费收入共计54832.64亿元,同比增长7.99%
Chan Ye Xin Xi Wang· 2025-12-05 03:00
数据来源:国家金融监督管理总局,智研咨询整理 知前沿,问智研。智研咨询是中国一流产业咨询机构,十数年持续深耕产业研究领域,提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力,专注于提供完善的产业解决方案,为您的投资决策赋能。 2025年1-10月全国原保险保费收入共计54832.64亿元,同比增长7.99%,全国累计原保险保费收入不同 险种类别中寿险占比最高,为32748.2亿元,占比59.72%。 2020年-2025年1-10月全国累计原保险保费收入统计图 上市企业:天茂集团(000627),中国平安(601318),中国人保(601319),新华保险(601336), 中国太保(601601),中国人寿(601628) 相关报告:智研咨询发布的《2026-2032年中国保险行业发展分析及投资前景预测报告》 ...
见费出单!非车险迎来新规
券商中国· 2025-11-07 04:36
Core Viewpoint - The implementation of the "reporting and operation integration" requirement for non-auto insurance will begin on November 1, which is seen as a significant regulatory change in the industry [2][9]. Group 1: Reporting and Operation Integration - The "reporting and operation integration" refers to the requirement that property insurance companies must issue policies and invoices only after receiving premiums, a shift from the previous practice of issuing policies before payment [3][4]. - This change aims to address two main issues: the rising accounts receivable due to the previous "non-fee issuance" practice and the potential for fraudulent premium reporting [3][4]. - The industry generally views this shift positively, as it is expected to alleviate the pressure of high accounts receivable and improve cash flow for non-auto insurance [3][5]. Group 2: Implementation Challenges - Insurance companies are currently preparing for the transition, which includes informing clients about the new "fee issuance" requirement and upgrading their systems [5]. - There are concerns regarding the initial difficulties in adapting to this new requirement, particularly for certain non-auto insurance products like cargo insurance, where determining the exact premium can be challenging [5][6]. Group 3: Payment Flexibility - The regulatory body has allowed for installment payments for large projects, with specific guidelines for premium payments exceeding a certain amount [7][8]. - The minimum installment payment is set at 200,000 yuan, and the first payment must be at least 25% of the total premium [8]. Group 4: New Product Reporting - The new regulations also emphasize the need for strict adherence to rate management and the proper use of insurance terms, preventing companies from altering agreed-upon terms through unofficial means [9]. - Companies are required to start reporting new product terms from November 1, with a complete update of all non-auto insurance products expected by the end of 2026 [9][10].
新股发行及今日交易提示-20251029
HWABAO SECURITIES· 2025-10-29 08:30
New Stock Issuance - Multiple companies are experiencing significant abnormal fluctuations in stock prices, including 香农芯创 (300475) with a notice date of 2025-10-24[1] - 天普股份 (605255) reported on 2025-10-21[1] - 生益电子 (688183) and 达华智能 (002512) both reported on 2025-10-29[1] Trading Alerts - 21 companies have been flagged for abnormal trading activities as of 2025-10-29, indicating potential volatility in the market[1] - ST新华锦 (600735) and 汇绿生态 (001267) are among those with recent alerts on 2025-10-29[1] - The report includes links to detailed announcements for each company, providing transparency and further information for investors[1] Market Trends - The report highlights a trend of increased scrutiny on companies with abnormal stock price movements, suggesting a potential shift in regulatory focus[1] - Investors are advised to monitor these stocks closely due to the heightened risk associated with abnormal fluctuations[1]
费用使用不真实,国华人寿分公司被罚!
Shen Zhen Shang Bao· 2025-10-17 04:36
Core Points - Guohua Life Insurance Co., Ltd. Shanghai Branch was fined 340,000 yuan due to false expense usage [1][2] - Zhong Heqing, the former director of Guohua Life Insurance Shanghai Branch, received a warning and was fined 50,000 yuan [1][2] Company Overview - Guohua Life Insurance was established in November 2007, headquartered in Shanghai, with a registered capital of 4.846 billion yuan [2][3] - The company is a nationwide, joint-stock professional life insurance company approved by the former China Insurance Regulatory Commission [2][3] Shareholder Structure - The company has seven shareholders, with Tianmao Group being the largest, holding 51% of the shares [3] - Other shareholders include Ningbo Kaiyihe (15.05%), Ningbo Boyonglun (13.91%), Ningbo Hanshengxin (9.47%), Hubei Hongtai (9.22%), Wuhan Urban Construction Group (1.14%), and Wuhan Jiang'an State-owned Assets (0.23%) [3] - Liu Yiqian is the actual controller of Guohua Life Insurance [3] Financial Performance - From 2014 to 2022, Guohua Life Insurance reported net profits of 1.427 billion yuan, 1.649 billion yuan, 1.653 billion yuan, 2.733 billion yuan, 2.055 billion yuan, 2.216 billion yuan, 1.111 billion yuan, 849 million yuan, and 484 million yuan respectively [3] - In 2023, the company experienced a significant downturn, reporting a net loss of 1.155 billion yuan [3] - As of the end of 2023, the company had an undistributed profit of 7.899 billion yuan on its consolidated balance sheet [3]
鑫闻界|浮沉A股29年,天茂集团摘牌,国华人寿隐忧待解
Qi Lu Wan Bao· 2025-09-30 08:44
Core Viewpoint - Tianmao Group, controlled by Liu Yiqian, has voluntarily delisted from the A-share market after 29 years due to continuous losses at its subsidiary, Guohua Life Insurance, and difficulties in disclosing its 2024 annual report [2][9]. Company History - Tianmao Group was originally established as Zhongtian Co., Ltd. in November 1993 and was later renamed Baike Pharmaceutical before becoming Tianmao Group in 2006 [3][5]. - Liu Yiqian became the largest shareholder of Baike Pharmaceutical in 2001, acquiring 28.97% of the shares for 206 million [3]. Financial Performance - Tianmao Group's performance improved significantly after acquiring 51% of Guohua Life in 2015, with revenue soaring to 16.99 billion in 2016, a 14-fold increase, and a net profit of 1.779 billion [5]. - However, Guohua Life faced declining profitability from 2020 to 2023, with net profits dropping from 1.11 billion to a loss of 1.155 billion in 2023 [8][9]. Regulatory Challenges - The company has been under investigation by the China Securities Regulatory Commission (CSRC) for failing to disclose its annual report on time, leading to its eventual delisting [9][10]. - Guohua Life's solvency ratios fell below regulatory requirements, prompting significant capital injections and raising concerns about its financial health [6][8]. Delisting Process - Tianmao Group submitted its application for voluntary delisting on September 4, 2025, and the Shenzhen Stock Exchange decided to terminate its listing on September 25, 2025, with the actual delisting occurring on September 30, 2025 [9][10]. Investor Concerns - Investors have raised concerns regarding the low cash option price of 1.60 per share, which is significantly below the net asset value of 4.41 per share, leading to accusations of market manipulation [10][11]. - The stock price of Tianmao Group has dropped over 50% since the announcement of its annual report difficulties, from 3.38 to 1.45 per share [11].
新股发行及今日交易提示-20250929





HWABAO SECURITIES· 2025-09-29 09:57
New Stock Issuance - New stock issuance for Daoshengtianhe (Code: 780026) priced at 5.98 RMB on September 29, 2025[1] - Offer period for the acquisition of Shangwei New Materials (Code: 688585) is from September 29, 2025, to October 28, 2025[1] Delisting and Trading Alerts - Zitian Tui (Code: 300280) is in the delisting preparation period with 4 trading days remaining until the last trading day[1] - Significant abnormal fluctuations reported for Kaipu Cloud (Code: 688228) on September 25, 2025[1] Recent Announcements - Multiple companies including Zhonghuan Hailu (Code: 301040) and Shenhuafa A (Code: 000020) have recent announcements regarding their stock activities[1] - A total of 30 companies have made announcements regarding stock fluctuations and trading activities in the past week[1]
9月29日早间重要公告一览
Xi Niu Cai Jing· 2025-09-29 03:57
Group 1 - Zhiguang Electric plans to acquire minority stakes in its subsidiary Zhiguang Energy Storage through a combination of share issuance and cash payment, leading to a temporary suspension of its stock trading for up to 10 trading days [1] - Guangbo Co. has been awarded a procurement project by the State Grid Corporation of China, confirming its status as one of the successful bidders for office and industrial supplies [2] - Dongguan Holdings announced the resignation of its chairman Wang Chong'en due to work changes, with Lin Yongsen appointed as the interim chairman [2] Group 2 - *ST Tianmao's stock will be delisted on September 30, 2025, following the Shenzhen Stock Exchange's decision to terminate its listing [3] - Salt Lake Co. has entered the trial production phase for its 40,000 tons/year integrated lithium salt project, successfully producing qualified battery-grade lithium carbonate [5] - Xindazheng plans to adjust its share repurchase price limit from 13.78 yuan to 16.79 yuan per share, maintaining a total repurchase fund of 10 million to 20 million yuan [7] Group 3 - Xindazheng intends to acquire 75.15% of Jiaxin Liheng's equity through share issuance and cash payment, with the transaction price yet to be determined [9] - Koli'er's actual controller plans to reduce his stake by up to 2% of the company's total shares due to funding needs [11] - United Precision's two actual controllers plan to collectively reduce their stake by up to 3% of the company's total shares for personal financial reasons [13] Group 4 - Yipinhong's subsidiary has received a drug registration certificate for L-carnitine oral solution, which is classified as a chemical drug [15] - Tiancheng Self-Control plans to establish a wholly-owned subsidiary in Japan and invest in a warehouse and production base with a budget of up to 10 million yuan [17] - Ningbo Huaxiang's joint venture has obtained a patent license from Jilin University for PEEK technology, which will enhance its R&D capabilities [21] Group 5 - Bright Dairy's subsidiary Synlait Milk Limited plans to sell its North Island assets to Abbott for $170 million, aiming to focus on core business development [23] - Nanjing Pharmaceutical has signed a strategic investment agreement with Guangzhou Baiyunshan Pharmaceutical Group, with the latter acquiring 11.04% of Nanjing Pharmaceutical's shares [24] - Guoxing Optoelectronics' application for a private placement of A-shares has been accepted by the Shenzhen Stock Exchange [25] Group 6 - Hailianxun has received approval from the China Securities Regulatory Commission for its plan to merge with Hangqilun B through a share exchange [27] - CITIC Bank's risk director Hu Gang has resigned, with Jin Xinian appointed as the new risk director pending regulatory approval [29]
盘前必读丨央行三季度货政例会释放重要信号;有色金属、石化化工等行业迎政策支持
Di Yi Cai Jing· 2025-09-28 23:19
Group 1 - The U.S. stock market experienced a broad increase, with the Dow Jones rising by 0.65%, the Nasdaq by 0.44%, and the S&P 500 by 0.59% [4] - Major technology stocks showed mixed results, with Oracle down 2.7%, Meta down 0.7%, and Tesla up 4.0% [4] - The Nasdaq China Golden Dragon Index fell by 1.6%, with Alibaba, NetEase, and Baidu each dropping over 2% [4] Group 2 - The People's Bank of China emphasized maintaining ample liquidity and guiding financial institutions to increase credit supply to match economic growth and price expectations [5] - The Ministry of Industry and Information Technology projected an average annual growth of around 5% for the non-ferrous metals industry from 2025 to 2026 [5] - The petrochemical industry is expected to see an average annual growth of over 5% during the same period, with significant improvements in technological innovation and environmental performance [6] Group 3 - The National Development and Reform Commission highlighted the importance of private investment as a key indicator of economic activity and stability [7] - The 2025 World New Energy Vehicle Conference focused on expanding market consumption and optimizing tax incentives for new energy vehicles [8] - The National Bureau of Statistics reported that profits of large industrial enterprises increased by 0.9% year-on-year in the first eight months of 2025 [8] Group 4 - The State-owned Assets Supervision and Administration Commission emphasized the need for state-owned enterprises to enhance operational efficiency and focus on high-quality investment [9] - Jiangsu Province announced adjustments to its vehicle trade-in policy, affecting the implementation of subsidies [10][11] - The company Ningbo Huaxiang signed a patent licensing agreement with Jilin University for PEEK industrialization technology [16] Group 5 - The company *ST Tianmao will have its stock delisted on September 30, 2025, following a decision by the Shenzhen Stock Exchange [20] - Huajing Securities anticipates that the A-share market may continue a volatile trend in the short term, with limited risks during the holiday period [21] - The company Moer Thread's IPO application was approved in just 88 days, reflecting improved efficiency in the review process for hard technology enterprises [14]